AbbVie

Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that Cell therapy is entering a bold new phase…

IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…

GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…

The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData

Approval marks Alembic’s 193rd final ANDA approval in the United States market

Tavapadon’s profile and efficacy could redefine its role in Parkinson’s treatment, but market positioning remains a challenge,…

Cobenfy is a twice-daily oral medication that combines xanomeline, a muscarinic receptor agonist, and trospium chloride, a…

2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry

Sionna Therapeutics secures exclusive global rights to develop and commercialise advanced CF compounds, strengthening its pipeline…

Strategic shift to Skyrizi and Rinvoq strengthens AbbVie's dominance in immunology despite Humira's biosimilar competition